infliximab (Remsima )
Application Details
HSE100104
26017
infliximab
Remsima
Celltrion Healthcare
08/04/2026
30/04/2021
Application Status
Rapid Review Completed
24/04/2026
Rapid Review Commissioned
08/04/2026
Pricing and Reimbursement Application Complete
08/04/2026